The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
Open accessAbstract
The global threat to public health posed by emerging multidrug-resistant bacteria in the past few years necessitates the development of novel approaches to combat bacterial infections. Endolysins encoded by bacterial viruses (or phages) represent one promising avenue of investigation. These enzyme-based antibacterials efficiently kill Gram-positive bacteria upon contact by specific cell wall hydrolysis. However, a major hurdle in their exploitation as antibacterials against Gram-negative pathogens is the impermeable lipopolysaccharide layer surrounding their cell wall. Therefore, we developed and optimized an approach to engineer these enzymes as outer membrane-penetrating endolysins (Artilysins), rendering them highly bactericidal against Gram-negative pathogens, including Pseudomonas aeruginosa and Acinetobacter baumannii . Artilysins combining a polycationic nonapeptide and a modular endolysin are able to kill these (multidrug-resistant) strains in vitro with a 4 to 5 log reduction within 30 min. We show that the activity of Artilysins can be further enhanced by the presence of a linker of increasing length between the peptide and endolysin or by a combination of both polycationic and hydrophobic/amphipathic peptides. Time-lapse microscopy confirmed the mode of action of polycationic Artilysins, showing that they pass the outer membrane to degrade the peptidoglycan with subsequent cell lysis. Artilysins are effective in vitro (human keratinocytes) and in vivo ( Caenorhabditis elegans ). IMPORTANCE Bacterial resistance to most commonly used antibiotics is a major challenge of the 21st century. Infections that cannot be treated by first-line antibiotics lead to increasing morbidity and mortality, while millions of dollars are spent each year by health care systems in trying to control antibiotic-resistant bacteria and to prevent cross-transmission of resistance. Endolysins—enzymes derived from bacterial viruses—represent a completely novel, promising class of antibacterials based on cell wall hydrolysis. Specifically, they are active against Gram-positive species, which lack a protective outer membrane and which have a low probability of resistance development. We modified endolysins by protein engineering to create Artilysins that are able to pass the outer membrane and become active against Pseudomonas aeruginosa and Acinetobacter baumannii , two of the most hazardous drug-resistant Gram-negative pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE GENETICS OF CAENORHABDITIS ELEGANS
Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,081
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 3×
“aeruginosa LPS has a high phosphate content and consequently a higher concentration of divalent cations stabilizing its structure (12).”
BackgroundInfluentialC. elegans: des neurones et des gènes
Gally, C., & Bessereau, J.-L. (2003) · médecine/sciences · doi:10.1051/medsci/20031967725 · Cited by 3,287
Stiernagle, T. (2006) · WormBook · doi:10.1895/wormbook.1.101.1 · Cited by 2,755
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879
Church, D., Elsayed, S., Reid, O., Winston, B., & Lindsay, R. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.403-434.2006 · Cited by 1,876
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Tan, M.-W., Mahajan-Miklos, S., & Ausubel, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.715 · Cited by 1,002
Significance of antibiotics in the environment
Kummerer, K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg293 · Cited by 745
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Genetic Recombination in Pseudomonas aeruginosa
HOLLOWAY, B. W. (1955) · Microbiology · doi:10.1099/00221287-13-3-572 · Cited by 650
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Antimicrobial Properties of Lysozyme in Relation to Foodborne Vegetative Bacteria
Masschalck, B., & Michiels, C. W. (2003) · Critical Reviews in Microbiology · doi:10.1080/713610448 · Cited by 442
Nelson, D. C., Schmelcher, M., Rodriguez-Rubio, L., Klumpp, J., Pritchard, D. G., Dong, S., & Donovan, D. M. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00007-4 · Cited by 372
Pseudomonas aeruginosa Population Structure Revisited
Pirnay, J.-P., Bilocq, F., Pot, B., Cornelis, P., Zizi, M., Van Eldere, J., Deschaght, P., Vaneechoutte, M., Jennes, S., Pitt, T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007740 · Cited by 307
Self-citationIdentification of novel antimicrobials using a live-animal infection model
Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., & Ausubel, F. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604055103 · Cited by 294
The non‐enzymatic microbicidal activity of lysozymes
Düring, K., Porsch, P., Mahn, A., Brinkmann, O., & Gieffers, W. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00405-6 · Cited by 291
Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus
Park, I. Y., Park, C. B., Kim, M. S., & Kim, S. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01238-1 · Cited by 283
Lycotoxins, Antimicrobial Peptides from Venom of the Wolf SpiderLycosa carolinensis
Yan, L., & Adams, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2059 · Cited by 208
Lysins: the arrival of pathogen-directed anti-infectives
Pastagia, M., Schuch, R., Fischetti, V. A., & Huang, D. B. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.061028-0 · Cited by 205
Briers, Y., Volckaert, G., Cornelissen, A., Lagaert, S., Michiels, C. W., Hertveldt, K., & Lavigne, R. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05870.x · Cited by 197
Self-citationSchmelcher, M., Powell, A. M., Becker, S. C., Camp, M. J., & Donovan, D. M. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07050-11 · Cited by 172
Characterization of Modular Bacteriophage Endolysins from Myoviridae Phages OBP, 201φ2-1 and PVP-SE1
Walmagh, M., Briers, Y., Santos, S. R. B., Azeredo, J., & Lavigne, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036991 · Cited by 169
Self-citationStructural engineering of a phage lysin that targets Gram-negative pathogens
Lukacik, P., Barnard, T. J., Keller, P. W., Chaturvedi, K. S., Seddiki, N., Fairman, J. W., Noinaj, N., Kirby, T. L., Henderson, J. P., Steven, A. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203472109 · Cited by 160
Briers, Y., Walmagh, M., & Lavigne, R. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04931.x · Cited by 159
Self-citationIbrahim, H. R., Kato, A., & Kobayashi, K. (1991) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00011a039 · Cited by 138
Ibrahim, H. R., Yamada, M. C., Matsushita, K., Kobayashi, K., & Kato, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37654-8 · Cited by 135
Characterization of five novel endolysins from Gram-negative infecting bacteriophages
Walmagh, M., Boczkowska, B., Grymonprez, B., Briers, Y., Drulis‐Kawa, Z., & Lavigne, R. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4294-7 · Cited by 119
Self-citationIdentification and characterization of a highly thermostable bacteriophage lysozyme
Lavigne, R., Briers, Y., Hertveldt, K., Robben, J., & Volckaert, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4301-y · Cited by 104
Self-citationThe high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144
Briers, Y., Schmelcher, M., Loessner, M. J., Hendrix, J., Engelborghs, Y., Volckaert, G., & Lavigne, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.161 · Cited by 92
Self-citationExpression of a Novel P22 ORFan Gene Reveals the Phage Carrier State in Salmonella Typhimurium
Cenens, W., Mebrhatu, M. T., Makumi, A., Ceyssens, P., Lavigne, R., Houdt, R. V., Taddéi, F., & Aertsen, A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003269 · Cited by 86
Self-citationIbrahim, H. R., Kobayashi, K., & Kato, A. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00031a029 · Cited by 68
Morita, M., Tanji, Y., Orito, Y., Mizoguchi, K., Soejima, A., & Unno, H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02587-x · Cited by 63
Corte, P. D., Verween, G., Verbeken, G., Rose, T., Jennes, S., Coninck, A. L. D., Roseeuw, D. I., Vanderkelen, A., Kets, E., Haddow, D. B., et al. (2011) · Cell and Tissue Banking · doi:10.1007/s10561-011-9247-3 · Cited by 57
Self-citationIbrahim, H. R., Yamada, M. C., Kobayashi, K., & Kato, A. (1992) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.56.1361 · Cited by 43
Cited by
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance
Lin, D. M., Koskella, B., & Lin, H. C. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i3.162 · Cited by 1,135
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 998
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Metadata
- Authors
- Briers, Y., Walmagh, M., Van Puyenbroeck, V., Cornelissen, A., Cenens, W., Aertsen, A., Oliveira, H., Azeredo, J., Verween, G., Pirnay, J.-P., Miller, S., Volckaert, G., & Lavigne, R.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2014-08-29
- Volume
- 5
- Issue
- 4
- Pages
- e01379-14
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2152343141
- Cited by
- 421
- References
- 37
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.